Why ResMed Inc. Shares Could Fall to $40

While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.

What: Shares of ResMed (NYSE: RMD  ) slipped 1% today after Northland Capital downgraded the medical equipment distributor from market perform to underperform.

So what: Along with the downgrade, analyst Suraj Kalia reiterated his price target of $40, representing about 20% worth of downside to Friday's close. So while momentum traders might be attracted to ResMed's price strength in recent months, Kalia's call could reflect a sense on Wall Street that the company's operating risks are being largely overlooked.

Now what: According to Northland, ResMed's risk/reward trade-off is rather unattractive at this point. "Our recent checks in the CPAP space highlight numerous forces that will, over time, work in concert to squeeze margins and top-line growth," said Kalia. "As we have said in our initiation report (10/07/13), ResMed's model is highly sensitive to operating margins, and every 100 bps reduction in margins reduces equity value/share by $2. We believe consensus forward estimates, especially margin profiles are unrealistic." When you couple that downbeat view with ResMed's steep-ish 20-plus P/E, it's tough to disagree with Northland's bearishness. 

More reliable ways to build wealth
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2972893, ~/Articles/ArticleHandler.aspx, 9/1/2015 10:53:06 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Brian Pacampara

I take a look at big 10% moves, as well as stock-shaking analyst calls, on a daily basis for The Fool. While I don't believe in active trading, closely monitoring Mr. Market's mood swings can help identify long-term opportunities.

Today's Market

updated 1 hour ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:00 PM
RMD $50.75 Down -1.19 -2.29%
ResMed, Inc. CAPS Rating: ****